the observation that atropine inhibits serum pp levels in men i patients with endocrine pancreatic tumors throws doubt on the clinical usefulness of an atropine suppression test for pp in the diagnosis of pancreatic endocrine tumors .
C0025267
men i
C0242363
endocrine pancreatic tumors